慢性病管理市場規模、佔有率、成長分析（按疾病類型、管理類型、最終用途、技術和地區）- 2025-2032 年產業預測

2023 年全球慢性病管理市場規模價值 61 億美元，預計將從 2024 年的 69.8 億美元成長到 2032 年的 206.3 億美元，預測期內（2025-2032 年）的複合年成長率為 14.5%。

全球慢性病管理市場正在經歷顯著成長，這是因為隨著生活方式的改變，尤其是在都市區，慢性病的盛行率不斷上升。網路普及率的提高提高了人們的健康意識，越來越多的人開始使用線上健康資訊和遠端醫療服務，從而擴大了醫療機構的患者群。此外，都市區的空氣污染導致呼吸系統疾病增加，進一步增加了對慢性病管理解決方案的需求。老齡化社會進一步增加了需求，因為老年人更容易出現長期健康問題。此外，公司透過健康計畫重視員工健康，推動了市場成長，許多公司投資於慢性病管理舉措以支持員工的健康。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

慢性病管理市場規模（依疾病類型和複合年成長率）（2025-2032）

• 市場概覽
• 糖尿病
• 心血管疾病
• 慢性呼吸系統疾病
• 癌症
• 慢性腎臟病

慢性病管理市場規模（按管理類型和複合年成長率）（2025-2032）

• 市場概覽
• 生活方式管理
• 藥物管理
• 遠端醫療服務
• 病患教育
• 監控服務

慢性病管理市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 醫療保健提供者
• 病人
• 製藥公司
• 保險公司
• 研究組織

慢性病管理市場規模：依技術及複合年成長率（2025-2032）

• 市場概覽
• 穿戴式裝置
• 行動應用程式
• 雲端運算
• 電子健康記錄
• 遠端醫療

慢性病管理市場規模：按地區和複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Optum, Inc.（USA）
• Medtronic（Ireland）
• Koninklijke Philips NV（Netherlands）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Cognizant（USA）
• Infosys Limited（India）
• EXL Service Holdings, Inc.（USA）
• Epic Systems Corporation（USA）
• WellSky（USA）
• ZeOmega（USA）
• Health Catalyst（USA）
• Pegasystems Inc.（USA）
• Cerner Corporation（USA）
• Humana Inc.（USA）
• Teladoc Health, Inc.（USA）
• ChartSpan（USA）
• Signallamp Health（USA）
• Engooden Health（USA）
• Optimize Health（USA）

結論和建議

Global Chronic Disease Management Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.98 billion in 2024 to USD 20.63 billion by 2032, growing at a CAGR of 14.5% during the forecast period (2025-2032).

The global chronic disease management market is experiencing significant growth driven by the rising prevalence of chronic diseases, particularly in urban areas influenced by changing lifestyle patterns. Increased internet accessibility is enhancing health awareness and expanding Healthcare organizations' patient bases as more individuals utilize online health information and telemedicine services. Additionally, urban air pollution is contributing to a rise in respiratory diseases, further elevating the demand for chronic disease management solutions. The aging population adds another layer of demand, as older individuals are more prone to long-term health issues. Moreover, corporate emphasis on employee health through wellness programs accelerates market growth, with many companies investing in chronic disease management initiatives to support their workforce's well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chronic Disease Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chronic Disease Management Market Segments Analysis

Global Chronic Disease Management Market is segmented by Disease Type, Management Type, End Use, Technology and region. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular Diseases, Chronic Respiratory Diseases, Cancer and Chronic Kidney Diseases. Based on Management Type, the market is segmented into Lifestyle Management, Medication Management, Telehealth Services, Patient Education and Monitoring Services. Based on End Use, the market is segmented into Healthcare Providers, Patients, Pharmaceutical Companies, Insurance Companies and Research Organizations. Based on Technology, the market is segmented into Wearable Devices, Mobile Applications, Cloud Computing, Electronic Health Records and Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chronic Disease Management Market

The Global Chronic Disease Management market is experiencing substantial growth driven by rapid digitalization, which is significantly enhancing health awareness among individuals through real-time health monitoring technologies. Innovations such as smartwatches and fitness bands empower users to continuously track vital signs like blood pressure and heart rate, allowing them to monitor their health conditions effectively. As a result, people are increasingly proactive about their well-being, leading to a rise in patient consultations for fitness and health management. This trend underscores the importance of leveraging technology in chronic disease management, fostering a more informed and health-conscious population.

Restraints in the Global Chronic Disease Management Market

While technological advancements in the healthcare sector are significantly benefiting developed economies, several factors could hinder the growth of the global chronic disease management market. In low-income countries, budget limitations pose challenges to effective treatment for chronic diseases. These financial restrictions prevent the adoption of new technologies within their healthcare systems, ultimately affecting medical outcomes. The disparity in resources and lack of infrastructure in these regions can create a substantial barrier to progress, leading to a slower evolution in chronic disease management practices. Therefore, addressing these constraints is essential for achieving equitable healthcare improvements globally.

Market Trends of the Global Chronic Disease Management Market

The Global Chronic Disease Management market is witnessing a significant shift driven by the rapid development and integration of telemedicine and remote monitoring technologies. This trend has been accelerated by the COVID-19 pandemic, highlighting the necessity of efficient healthcare delivery systems. Telemedicine facilitates convenient consultations for patients, particularly in underserved and rural regions, improving access to essential medical services. Furthermore, remote monitoring allows healthcare providers to track symptoms and health indicators in real-time, promoting early interventions that enhance patient outcomes. As a result, the market is poised for growth, characterized by an increasing demand for innovative solutions that enable effective management of chronic diseases.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Chronic Disease Management Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Diabetes
• Cardiovascular Diseases
• Chronic Respiratory Diseases
• Cancer
• Chronic Kidney Diseases

Global Chronic Disease Management Market Size by Management Type & CAGR (2025-2032)

• Market Overview
• Lifestyle Management
• Medication Management
• Telehealth Services
• Patient Education
• Monitoring Services

Global Chronic Disease Management Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Healthcare Providers
• Patients
• Pharmaceutical Companies
• Insurance Companies
• Research Organizations

Global Chronic Disease Management Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Wearable Devices
• Mobile Applications
• Cloud Computing
• Electronic Health Records
• Telemedicine

Global Chronic Disease Management Market Size & CAGR (2025-2032)

• North America (Disease Type, Management Type, End Use, Technology)
  • US
  • Canada
• Europe (Disease Type, Management Type, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Type, Management Type, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Type, Management Type, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Type, Management Type, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Optum, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EXL Service Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellSky (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeOmega (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pegasystems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChartSpan (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signallamp Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Engooden Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optimize Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations